CurrentRheuma
Get Weekly

Topic · page 6 of 7

Sjögren's disease & overlap diseases

Sjögren's disease, its glandular and extraglandular disease and lymphoma risk; mixed, undifferentiated and overlap connective tissue disease

Briefs 201–240 of 272 placed here, newest publication first

Briefs in Sjögren's disease & overlap diseases

Newest publication first

  1. Ann Rheum Dis

    Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren’s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial

    Randomized controlled trial

  2. Arthritis Rheumatol

    Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)

    Secondary analysis

  3. Arthritis Rheumatol

    Association of Combined Anti‐Ro52 / TRIM21 and Anti‐Ro60 / SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation

    Cohort study

  4. RMD Open

    Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study

    Cohort study

  5. Semin Arthritis Rheum

    Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group

    Research article

  6. Semin Arthritis Rheum

    The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation

    Research article

  7. RMD Open

    Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren’s syndrome

    Cohort study

  8. Arthritis Res Ther

    CXCL9 may serve as a potential biomarker for primary Sjögren’s syndrome with extra-glandular manifestations

    Cross-sectional study

  9. Clin Exp Rheumatol

    Influence of doctor-patient relationships and health-related factors on the medical satisfaction of patients with Sjögren's disease

    Cross-sectional study

  10. Clin Exp Rheumatol

    Investigation of pyroptosis-related hub genes and the immune microenvironment in primary Sjögren's syndrome

    Mechanistic study

  11. Arthritis Rheumatol

    Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included

    Diagnostic or prognostic study

  12. Ann Rheum Dis

    Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis

    Mechanistic study

  13. Joint Bone Spine

    Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome

    Cross-sectional study

  14. Clin Exp Rheumatol

    Longitudinal evaluation of major salivary gland functioning in Sjögren's disease patients in a prospective standard-of-care cohort

    Cohort study

  15. Clin Exp Rheumatol

    Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study

    Cross-sectional study

  16. Clin Exp Rheumatol

    Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patients

    Mechanistic study

  17. Clin Exp Rheumatol

    Abatacept use for 24 weeks has a limited effect on salivary gland inflammation in Sjögren's disease patients

    Secondary analysis

  18. Arthritis Rheumatol

    Multimodal Single‐Cell Sequencing of B Cells in Primary Sjögren's Syndrome

    Mechanistic study

  19. Clin Exp Rheumatol

    Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes

    Cross-sectional study

  20. Clin Exp Rheumatol

    Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis

    Cross-sectional study

  21. J Rheumatol

    The Novel OMERACT Ultrasound Scoring System for Salivary Gland Changes in Patients With Sjögren Syndrome Is Associated With MRI and Salivary Flow Rates

    Cross-sectional study

  22. RMD Open

    Comparison between primary Sjögren’s disease patients with high or low level of dryness

    Cross-sectional study

  23. Clin Exp Rheumatol

    The role of imbalanced CD226/TIGIT on activated peripheral double-negative T cells in the pathogenesis of primary Sjögren's syndrome

    Mechanistic study

  24. RMD Open

    Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype

    Cohort study

  25. Clin Exp Rheumatol

    Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome

    Cross-sectional study

  26. Lupus

    Predictors for future development of systemic lupus erythematosus in Korean Sjögren’s syndrome patients

    Cohort study

  27. Arthritis Res Ther

    Identification of potential susceptibility genes in patients with primary Sjögren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing

    Research article

  28. Arthritis Res Ther

    Causal associations of Sjögren’s syndrome with cancers: a two-sample Mendelian randomization study

    Research article

  29. Semin Arthritis Rheum

    The phenotype of mixed connective tissue disease patients having associated interstitial lung disease

    Cohort study

  30. Arthritis Res Ther

    Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling

    Mechanistic study

  31. Clin Exp Rheumatol

    Characterisation of crevicular fluid microbiota in primary Sjögren's syndrome

    Cohort study

  32. RMD Open

    Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response

    Secondary analysis

  33. Arthritis Rheumatol

    Association Between Bruton's Tyrosine Kinase Gene Overexpression and Risk of Lymphoma in Primary Sjögren's Syndrome

    Case-control study

  34. Clin Exp Rheumatol

    Implant supported overdentures in Sjögren's disease patients: a multicentre prospective cohort study

    Cohort study

  35. Clin Exp Rheumatol

    Can ultrasound of the major salivary glands differentiate Sjögren's disease from its major mimics?

    Diagnostic or prognostic study

  36. Clin Exp Rheumatol

    The diagnostic power of salivary electrolytes for Sjögren's disease: a systematic literature review and meta-analysis

    Meta-analysis

  37. Rheumatology (Oxford)

    Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease

    Cohort study

  38. Rheumatology (Oxford)

    Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial

    Randomized controlled trial

  39. Clin Exp Rheumatol

    Utilisation of primary healthcare services by Sjögren's syndrome patients in the Community of Madrid and associated factors: a population-based cross-sectional study

    Cross-sectional study

  40. Clin Exp Rheumatol

    Salivary gland 18F-FDG-PET/CT uptake patterns in Sjögren's syndrome and giant cell arteritis patients

    Cohort study

All 272 Briefs in ExploreShowing Briefs 201–240 of 272, newest first